Part 1: Mucormycosis: prevalence, risk factors, clinical features, and diagnosis

References

• Danion F, Aguilar C, Catherinot E, et al. Mucormycosis: new developments into a persistently devastating infection. Semin Respir Crit Care Med. 2015;36(5):692–705. doi: 10.1055/s-0035-1562896
   PubMed Web of Science ®Google Scholar
• Kwon-Chung KJ. Taxonomy of fungi causing mucormycosis and entomophthoramycosis (zygomycosis) and nomenclature of the disease: molecular mycologic perspectives. Clin Infect Dis. 2012;54(Suppl 1):S8–S15.
   PubMedGoogle Scholar
• Petrikkos G, Skiada A, Lortholary O, et al. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012;54(Suppl 1):S23–34. doi:10.1093/cid/cir866
   PubMed Web of Science ®Google Scholar
• Reid G, Lynch JP 3rd, Fishbein MC, et al. Mucormycosis. Semin Respir Crit Care Med. 2020;41:99–114.
   PubMed Web of Science ®Google Scholar
• Prakash H, Ghosh AK, Rudramurthy SM, et al. A prospective multicenter study on mucormycosis in India: epidemiology, diagnosis, and treatment. Med Mycol. 2019;57(4):395–402. doi:10.1093/mmy/myy060
   PubMed Web of Science ®Google Scholar
• Bigot J, Godmer A, Prudente L, et al. Diagnosis of mucormycosis using an intercalating dye-based quantitative PCR. Medical Mycology. 2022;60(4):60. doi:10.1093/mmy/myac015
   Web of Science ®Google Scholar
• Park BJ, Pappas PG, Wannemuehler KA, et al. Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006. Emerg Infect Dis. 2011;17:1855–1864.
   PubMed Web of Science ®Google Scholar
• Riley TT, Muzny CA, Swiatlo E, et al. Breaking the mold: a review of mucormycosis and current pharmacological treatment options. Ann Pharmacother. 2016;50(9):747–757. doi:10.1177/1060028016655425
   PubMed Web of Science ®Google Scholar
• Chander J, Singla N, Kaur M, et al. Saksenaea erythrospora, an emerging mucoralean fungus causing severe necrotizing skin and soft tissue infections - a study from a tertiary care hospital in north India. Infect Dis (Lond). 2017;49:170–177.
   PubMed Web of Science ®Google Scholar
• Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev. 2000;13(2):236–301.
   PubMed Web of Science ®Google Scholar
• Skiada A, Pagano L, Groll A, et al. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect. 2011;17:1859–1867.
   PubMed Web of Science ®Google Scholar
• Torres-Narbona M, Guinea J, Munoz P, et al. Zygomycetes and zygomycosis in the new era of antifungal therapies]. Rev Esp Quimioter. 2007;20:375–386.
   PubMed Web of Science ®Google Scholar
• Vilela R, Mendoza L. Human pathogenic entomophthorales. Clin Microbiol Rev. 2018;31(4):31.
   Web of Science ®Google Scholar
• Prabhu RM, Patel R. Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infect. 2004;10 Suppl 1:31–47.
   PubMed Web of Science ®Google Scholar
• Gomes MZ, Lewis RE, Kontoyiannis DP. Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species. Clin Microbiol Rev. 2011;24:411–445.
   PubMed Web of Science ®Google Scholar
• Prakash H, Chakrabarti A. Global epidemiology of mucormycosis. J Fungi (Basel). 2019;5(1):26.
   PubMedGoogle Scholar
• Hamilos G, Samonis G, Kontoyiannis DP. Pulmonary mucormycosis. Semin Respir Crit Care Med. 2011;32(6):693–702.
   PubMed Web of Science ®Google Scholar
• Chander J, Singla N, Kaur M, et al. Apophysomyces variabilis, an emerging and worrisome cause of primary cutaneous necrotizing infections in India. J Mycol Med. 2021;31(4):101197. doi:10.1016/j.mycmed.2021.101197
   PubMed Web of Science ®Google Scholar
• Rodriguez JY, Morales-Lopez SE, Rodriguez GJ, et al. Necrotizing fasciitis caused by Apophysomyces variabilis in an immunocompetent patient. Med Mycol Case Rep. 2018;20:4–6.
   PubMed Web of Science ®Google Scholar
• Guarro J, Chander J, Alvarez E, et al. Apophysomyces variabilis infections in humans. Emerg Infect Dis. 2011;17(1):134–135. doi:10.3201/eid1701.101139
   PubMed Web of Science ®Google Scholar
• Bonifaz A, Stchigel AM, Guarro J, et al. Primary cutaneous mucormycosis produced by the new species Apophysomyces mexicanus. J Clin Microbiol. 2014;52(12):4428–4431. doi:10.1128/JCM.02138-14
   PubMed Web of Science ®Google Scholar
• Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41(5):634–653. doi:10.1086/432579
   PubMed Web of Science ®Google Scholar
• Jeong W, Keighley C, Wolfe R, et al. The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Clin Microbiol Infect. 2019;25(1):26–34. doi:10.1016/j.cmi.2018.07.011
   PubMed Web of Science ®Google Scholar
• Petraitis V, Petraitiene R, Antachopoulos C, et al. Increased virulence of Cunninghamella bertholletiae in experimental pulmonary mucormycosis: correlation with circulating molecular biomarkers, sporangiospore germination and hyphal metabolism. Med Mycol. 2013;51(1):72–82. doi:10.3109/13693786.2012.690107
   PubMed Web of Science ®Google Scholar
• Spellberg B, Edwards J Jr., Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev. 2005;18(3):556–569.
   PubMed Web of Science ®Google Scholar
• Pyrgos V, Shoham S, Walsh TJ. Pulmonary zygomycosis. Semin Respir Crit Care Med. 2008;29(2):111–120.
   PubMed Web of Science ®Google Scholar
• Lazar SP, Lukaszewicz JM, Persad KA, et al. Rhinocerebral Mucor circinelloides infection in immunocompromised patient following yogurt ingestion. Del Med J. 2014;86:245–248.
   PubMedGoogle Scholar
• Lee SC, Billmyre RB, Li A, et al. Analysis of a food-borne fungal pathogen outbreak: virulence and genome of a Mucor circinelloides isolate from yogurt. MBio. 2014;5:e01390–14.
   PubMed Web of Science ®Google Scholar
• Liu M, Spellberg B, Phan QT, et al. The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice. J Clin Invest. 2010;120(6):1914–1924. doi:10.1172/JCI42164
   PubMed Web of Science ®Google Scholar
• Pagano L, Girmenia C, Mele L, et al. Infections caused by filamentous fungi in patients with hematologic malignancies. A report of 391 cases by GIMEMA Infection Program. Haematologica. 2001;86:862–870.
   PubMed Web of Science ®Google Scholar
• Shariati A, Moradabadi A, Chegini Z, et al. An overview of the management of the most important invasive fungal infections in patients with blood malignancies. Infect Drug Resist. 2020;13:2329–2354.
   PubMed Web of Science ®Google Scholar
• Kontoyiannis DP, Wessel VC, Bodey GP, et al. Zygomycosis in the 1990s in a tertiary-care cancer center. Clin Infect Dis. 2000;30(6):851–856. doi:10.1086/313803
   PubMed Web of Science ®Google Scholar
• Claustre J, Larcher R, Jouve T, et al. Mucormycosis in intensive care unit: surgery is a major prognostic factor in patients with hematological malignancy. Ann Intensive Care. 2020;10(1):74. doi:10.1186/s13613-020-00673-9
   PubMed Web of Science ®Google Scholar
• Marr KA, Carter RA, Crippa F, et al. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis. 2002;34(7):909–917. doi:10.1086/339202
   PubMed Web of Science ®Google Scholar
• Martino R, Subira M, Rovira M, et al. Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients. Br J Haematol. 2002;116(2):475–482. doi:10.1046/j.1365-2141.2002.03259.x
   PubMed Web of Science ®Google Scholar
• Kontoyiannis DP, Marr KA, Park BJ, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis. 2010;50:1091–1100.
   PubMed Web of Science ®Google Scholar
• Hammond SP, Baden LR, Marty FM. Mortality in hematologic malignancy and hematopoietic stem cell transplant patients with mucormycosis, 2001 to 2009. Antimicrob Agents Chemother. 2011;55(11):5018–5021.
   PubMed Web of Science ®Google Scholar
• Husain S, Silveira FP, Azie N, et al. Epidemiological features of invasive mold infections among solid organ transplant recipients: pATH Alliance(R) registry analysis. Med Mycol. 2017;55:269–277.
   PubMed Web of Science ®Google Scholar
• Lemonovich TL. Mold infections in solid organ transplantrRecipients. Infect Dis Clin North Am. 2018;32:687–701.
   PubMed Web of Science ®Google Scholar
• Chitasombat MN, Kontoyiannis DP. Treatment of mucormycosis in transplant patients: role of surgery and of old and new antifungal agents. Curr Opin Infect Dis. 2016;29(4):340–345.
   PubMed Web of Science ®Google Scholar
• Singh N, Aguado JM, Bonatti H, et al. Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome. J Infect Dis. 2009;200(6):1002–1011. doi:10.1086/605445
   PubMed Web of Science ®Google Scholar
• Kennedy KJ, Daveson K, Slavin MA, et al. Mucormycosis in Australia: contemporary epidemiology and outcomes. Clin Microbiol Infect. 2016;22(9):775–781. doi:10.1016/j.cmi.2016.01.005
   PubMed Web of Science ®Google Scholar
• Arce-Salinas CA, Perez-Silva E. Mucormycosis complications in systemic lupus erythematosus. Lupus. 2010;19(8):985–988.
   PubMed Web of Science ®Google Scholar
• Kreiniz N, Bejar J, Polliack A, et al. Severe pneumonia associated with ibrutinib monotherapy for CLL and lymphoma. Hematol Oncol. 2018;36(1):349–354. doi:10.1002/hon.2387
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhu M, Bao Y, et al. Cutaneous mucormycosis caused by Rhizopus microsporus in an immunocompetent patient: a case report and review of literature. Medicine (Baltimore). 2018;97(25):e11141. doi:10.1097/MD.0000000000011141
   PubMed Web of Science ®Google Scholar
• Siwek GT, Dodgson KJ, de Magalhaes-Silverman M, et al. Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis. Clin Infect Dis. 2004;39:584–587.
   PubMed Web of Science ®Google Scholar
• Trifilio SM, Bennett CL, Yarnold PR, et al. Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy. Bone Marrow Transplant. 2007;39(7):425–429. doi:10.1038/sj.bmt.1705614
   PubMed Web of Science ®Google Scholar
• Pongas GN, Lewis RE, Samonis G, et al. Voriconazole-associated zygomycosis: a significant consequence of evolving antifungal prophylaxis and immunosuppression practices? Clin Microbiol Infect. 2009;15 Suppl 5:93–97.
   PubMed Web of Science ®Google Scholar
• Ambrosioni J, Bouchuiguir-Wafa K, Garbino J. Emerging invasive zygomycosis in a tertiary care center: epidemiology and associated risk factors. Int J Infect Dis. 2010;14(Suppl 3):e100–3.
   PubMed Web of Science ®Google Scholar
• Ibrahim AS, Spellberg B, Walsh TJ, et al. Pathogenesis of mucormycosis. Clin Infect Dis. 2012;54(Suppl 1):S16–22. doi:10.1093/cid/cir865
   PubMed Web of Science ®Google Scholar
• Rathi M, Sengupta U, Yadav TD, et al. Zygomycetes peritonitis in ambulatory peritoneal dialysis: case report and review of literature. Indian J Nephrol. 2014;24(4):252–254. doi:10.4103/0971-4065.133028
   PubMedGoogle Scholar
• Sedlacek M, Cotter JG, Suriawinata AA, et al. Mucormycosis peritonitis: more than 2 years of disease-free follow-up after posaconazole salvage therapy after failure of liposomal amphotericin B. Am J Kidney Dis. 2008;51(2):302–306. doi:10.1053/j.ajkd.2007.09.026
   PubMed Web of Science ®Google Scholar
• Radner AB, Witt MD, Edwards JE Jr. Acute invasive rhinocerebral zygomycosis in an otherwise healthy patient: case report and review. Clin Infect Dis. 1995;20(1):163–166.
   PubMed Web of Science ®Google Scholar
• Mignogna MD, Fortuna G, Leuci S, et al. Mucormycosis in immunocompetent patients: a case-series of patients with maxillary sinus involvement and a critical review of the literature. Int J Infect Dis. 2011;15(8):e533–40. doi: 10.1016/j.ijid.2011.02.005.
   PubMed Web of Science ®Google Scholar
• Ingram PR, Suthananthan AE, Rajan R, et al. Cutaneous mucormycosis and motor vehicle accidents: findings from an Australian case series. Med Mycol. 2014;52(8):819–825. doi:10.1093/mmy/myu054
   PubMed Web of Science ®Google Scholar
• Warkentien T, Rodriguez C, Lloyd B, et al. Invasive mold infections following combat-related injuries. Clin Infect Dis. 2012;55(11):1441–1449. doi:10.1093/cid/cis749
   PubMed Web of Science ®Google Scholar
• Tyll T, Lyskova P, Hubka V, et al. Early diagnosis of cutaneous mucormycosis due to Lichtheimia corymbifera after a traffic accident. Mycopathologia. 2016;181(1–2):119–124. doi:10.1007/s11046-015-9943-9
   PubMed Web of Science ®Google Scholar
• Venkatesh D, Dandagi S, Chandrappa PR, et al. Mucormycosis in immunocompetent patient resulting in extensive maxillary sequestration. J Oral Maxillofac Pathol. 2018;22:S112–S6.
   PubMedGoogle Scholar
• Patel A, Kaur H, Xess I, et al. A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India. Clin Microbiol Infect. 2020;26:944 e9–e15 .
   PubMed Web of Science ®Google Scholar
• Dravid A, Kashiva R, Khan Z, et al. Epidemiology, clinical presentation and management of COVID-19 associated mucormycosis: a single centre experience from Pune, Western India. Mycoses. 2022;65(5):526–540. doi:10.1111/myc.13435
   PubMed Web of Science ®Google Scholar
• Mishra Y, Prashar M, Sharma D, et al. Diabetes, COVID-19 and mucormycosis: clinical spectrum and outcome in a tertiary care medical center in Western India. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2021;15(4):102196. doi:10.1016/j.dsx.2021.102196
   PubMed Web of Science ®Google Scholar
• Monika P, Chandraprabha MN. Risks of mucormycosis in the current Covid-19 pandemic: a clinical challenge in both immunocompromised and immunocompetent patients. Mol Biol Rep. 2022;49(6):4977–4988.
   PubMed Web of Science ®Google Scholar
• Meher R, Wadhwa V, Kumar V, et al. COVID associated mucormycosis: a preliminary study from a dedicated COVID Hospital in Delhi. Am J Otolaryngol. 2022;43:103220.
   PubMed Web of Science ®Google Scholar
• Chakrabarti A, Das A, Mandal J, et al. The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus. Med Mycol. 2006;44:335–342.
   PubMed Web of Science ®Google Scholar
• Mamali V, Koutserimpas C, Zarkotou O, et al. Isolated cerebral mucormycosis caused by Lichtheimia species in a polytrauma patient. Diagnostics. 2022;12(2):12. doi:10.3390/diagnostics12020358
   Web of Science ®Google Scholar
• Ziaka M, Papakonstantinou E, Vasileiou E, et al. Paediatric cutaneous mucormycosis: a case report and review of the literature. Mycoses. 2022;65(7):674–682. doi:10.1111/myc.13452
   PubMed Web of Science ®Google Scholar
• Malhotra HS, Gupta P, Mehrotra D, et al. COVID-19 associated mucormycosis: staging and management recommendations (Report of a multi-disciplinary expert committee). J Oral Biol Craniofac Res. 2021;11:569–580.
   PubMedGoogle Scholar
• Arora R, Goel R, Khanam S, et al. Rhino-orbito-cerebral-mucormycosis during the COVID-19 second wave in 2021 - a preliminary report from a single hospital. Clin Ophthalmol. 2021;15:3505–3514.
   PubMed Web of Science ®Google Scholar
• Riad A, Shabaan AA, Issa J, et al. COVID-19-associated mucormycosis (CAM): case-series and global analysis of mortality risk factors. J Fungi (Basel). 2021;7(10):837. doi:10.3390/jof7100837
   PubMedGoogle Scholar
• Moreira J, Varon A, Galhardo MC, et al. The burden of mucormycosis in HIV-infected patients: a systematic review. J Infect. 2016;73(3):181–188. doi:10.1016/j.jinf.2016.06.013
   PubMed Web of Science ®Google Scholar
• Chakrabarti A, Singh R. Mucormycosis in India: unique features. Mycoses. 2014;57(Suppl 3):85–90.
   PubMedGoogle Scholar
• Almyroudis NG, Sutton DA, Linden P, et al. Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature. Am J Transplant. 2006;6(10):2365–2374. doi:10.1111/j.1600-6143.2006.01496.x
   PubMed Web of Science ®Google Scholar
• Lelievre L, Garcia-Hermoso D, Abdoul H, et al. Posttraumatic mucormycosis: a nationwide study in France and review of the literature. Medicine (Baltimore). 2014;93(24):395–404. doi:10.1097/MD.0000000000000221
   PubMed Web of Science ®Google Scholar
• Antoniadou A. Outbreaks of zygomycosis in hospitals. Clin Microbiol Infect. 2009;15 Suppl 5:55–59.
   PubMed Web of Science ®Google Scholar
• Gamarra S, Chaves MS, Cabeza MS, et al. Mucormycosis outbreak due to Rhizopus microsporus after arthroscopic anterior cruciate ligament reconstruction surgery evaluated by RAPD and MALDI-TOF mass spectrometry. J Mycol Med. 2018;28(4):617–622. doi:10.1016/j.mycmed.2018.09.002
   PubMed Web of Science ®Google Scholar
• Tilak R, Raina P, Gupta SK, et al. Cutaneous zygomycosis: a possible postoperative complication in immunocompetent individuals. Indian J Dermatol Venereol Leprol. 2009;75(6):596–599. doi:10.4103/0378-6323.57722
   PubMed Web of Science ®Google Scholar
• Kontoyiannis DP, Lewis RE. Invasive zygomycosis: update on pathogenesis, clinical manifestations, and management. Infect Dis Clin North Am. 2006;20(3):581–607. doi:10.1016/j.idc.2006.06.003. vi.
   PubMed Web of Science ®Google Scholar
• Geerlings SE, Hoepelman AI. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol. 1999;26:259–265.
   PubMed Web of Science ®Google Scholar
• Ibrahim AS, Kontoyiannis DP. Update on mucormycosis pathogenesis. Curr Opin Infect Dis. 2013;26(6):508–515.
   PubMed Web of Science ®Google Scholar
• Chamilos G, Lewis RE, Lamaris G, et al. Zygomycetes hyphae trigger an early, robust proinflammatory response in human polymorphonuclear neutrophils through toll-like receptor 2 induction but display relative resistance to oxidative damage. Antimicrob Agents Chemother. 2008;52(2):722–724. doi:10.1128/AAC.01136-07
   PubMed Web of Science ®Google Scholar
• Petrikkos G, Tsioutis C. Recent advances in the pathogenesis of mucormycoses. Clin Ther. 2018;40(6):894–902.
   PubMed Web of Science ®Google Scholar
• Webb BJ, Ferraro JP, Rea S, et al. Epidemiology and clinical features of invasive fungal infection in a US health care network. Open Forum Infect Dis. 2018;5:ofy187.
   PubMed Web of Science ®Google Scholar
• Gangneux JP, Bougnoux ME, Hennequin C, et al. An estimation of burden of serious fungal infections in France. J Mycol Med. 2016;26(4):385–390. doi:10.1016/j.mycmed.2016.11.001
   PubMed Web of Science ®Google Scholar
• Guinea J, Escribano P, Vena A, et al. Increasing incidence of mucormycosis in a large Spanish hospital from 2007 to 2015: epidemiology and microbiological characterization of the isolates. PLoS ONE. 2017;12(6):e0179136. doi:10.1371/journal.pone.0179136
   PubMed Web of Science ®Google Scholar
• Bitar D, Lortholary O, Le Strat Y, et al. Population-based analysis of invasive fungal infections, France, 2001-2010. Emerg Infect Dis. 2014;20(7):1149–1155. doi:10.3201/eid2007.140087
   PubMed Web of Science ®Google Scholar
• Bitar D, Van Cauteren D, Lanternier F, et al. Increasing incidence of zygomycosis (mucormycosis), France, 1997-2006. Emerg Infect Dis. 2009;15(9):1395–1401. doi:10.3201/eid1509.090334
   PubMed Web of Science ®Google Scholar
• Saegeman V, Maertens J, Meersseman W, et al. Increasing incidence of mucormycosis in University Hospital, Belgium. Emerg Infect Dis. 2010;16:1456–1458.
   PubMed Web of Science ®Google Scholar
• Lamoth F, Chung SJ, Damonti L, et al. Changing epidemiology of invasive mold infections in patients receiving azole prophylaxis. Clin Infect Dis. 2017;64(11):1619–1621. DOI:10.1093/cid/cix130
   PubMed Web of Science ®Google Scholar
• Hada M, Gupta P, Bagarhatta M, et al. Orbital magnetic resonance imaging profile and clinicoradiological correlation in COVID-19-associated rhino-orbital-cerebral mucormycosis: a single-center study of 270 patients from North India. Indian J Ophthalmol. 2022;70(2):641–648. doi:10.4103/ijo.IJO_1652_21
   PubMed Web of Science ®Google Scholar
• Patel R, Jethva J, Bhagat PR, et al. Rhino-orbital-cerebral mucormycosis: an epidemiological study from a tertiary care referral center in Western India. Indian J Ophthalmol. 2022;70(4):1371–1375. doi:10.4103/ijo.IJO_2943_21
   PubMed Web of Science ®Google Scholar
• Wei LW, Zhu PQ, Chen XQ, et al. Mucormycosis in mainland China: a systematic review of case reports. Mycopathologia. 2022;187(1):1–14. doi:10.1007/s11046-021-00607-4
   PubMed Web of Science ®Google Scholar
• Dimaka K, Mallis A, Naxakis SS, et al. Chronic rhinocerebral mucormycosis: a rare case report and review of the literature. Mycoses. 2014;57(11):699–702. doi:10.1111/myc.12219
   PubMed Web of Science ®Google Scholar
• Tedder M, Spratt JA, Anstadt MP, et al. Pulmonary mucormycosis: results of medical and surgical therapy. Ann Thorac Surg. 1994;57(4):1044–1050. doi:10.1016/0003-4975(94)90243-7
   PubMed Web of Science ®Google Scholar
• Tathe SP, Dani AA, Chawhan SM, et al. Gastric mucormycosis: diagnosis by imprint cytology. Diagn Cytopathol. 2016;44:820–822.
   PubMed Web of Science ®Google Scholar
• Alsaed OS, Yahia YM, Abdulaziz HAM, et al. An unusual case of large-vessel vasculitis. Eur J Case Rep Intern Med. 2018;5:000897.
   PubMedGoogle Scholar
• Lanternier F, Dannaoui E, Morizot G, et al. A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007). Clin Infect Dis. 2012;54(Suppl 1):S35–43. doi:10.1093/cid/cir880
   PubMed Web of Science ®Google Scholar
• Yadav T, Tiwari S, Gupta A, et al. Magnetic resonance imaging in coronavirus disease - 2019 associated Rhino-Orbital-Cerebral Mucormycosis (CA-ROCM) - imaging analysis of 50 consecutive patients. Curr Probl Diagn Radiol. 2022;51:112–120.
   PubMed Web of Science ®Google Scholar
• Sen M, Honavar SG, Bansal R, et al. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1. Indian J Ophthalmol. 2021;69:1670–1692.
   PubMed Web of Science ®Google Scholar
• Chandwani N, Dabhekar S, Selvi K, et al. Oral tissue involvement and probable factors in post-COVID-19 mucormycosis patients: a cross-sectional study. Healthcare (Basel). 2022;10(5):10. doi:10.3390/healthcare10050912
   Google Scholar
• Augustine HFM, White C, Bain J. Aggressive combined medical and surgical management of mucormycosis results in disease eradication in 2 pediatric patients. Plast Surg (Oakv). 2017;25(3):211–217.
   PubMedGoogle Scholar
• Mattingly JK, Ramakrishnan VR. Rhinocerebral mucormycosis of the optic nerve. Otolaryngol Head Neck Surg. 2016;155(5):888–889.
   PubMed Web of Science ®Google Scholar
• Karakurum B, Karatas M, Cagici AC, et al. Mucormycosis presenting with painful ophthalmoplegia. Acta Neurol Belg. 2005;105:201–205.
   PubMed Web of Science ®Google Scholar
• Shah K, Dave V, Bradoo R, et al. Orbital exenteration in rhino-oirbito-cerebral mucormycosis: a prospective analytical study with scoring system. Indian J Otolaryngol Head Neck Surg. 2019;71:259–265.
   PubMed Web of Science ®Google Scholar
• Gamaletsou MN, Sipsas NV, Roilides E, et al. Rhino-orbital-cerebral mucormycosis. Curr Infect Dis Rep. 2012;14:423–434.
   PubMed Web of Science ®Google Scholar
• Prabhu S, Alqahtani M, Al Shehabi M. A fatal case of rhinocerebral mucormycosis of the jaw after dental extractions and review of literature. J Infect Public Health. 2018;11(3):301–303.
   PubMed Web of Science ®Google Scholar
• Aras MH, Kara MI, Erkilic S, et al. Mandibular mucormycosis in immunocompromised patients: report of 2 cases and review of the literature. J Oral Maxillofac Surg. 2012;70(6):1362–1368.
   PubMed Web of Science ®Google Scholar
• Dubey S, Mukherjee D, Sarkar P, et al. COVID-19 associated rhino-orbital-cerebral mucormycosis: an observational study from Eastern India, with special emphasis on neurological spectrum. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2021;15(5):102267. doi:10.1016/j.dsx.2021.102267
   PubMed Web of Science ®Google Scholar
• Sreshta K, Dave TV, Varma DR, et al. Magnetic resonance imaging in rhino-orbital-cerebral mucormycosis. Indian J Ophthalmol. 2021;69(7):1915–1927. doi:10.4103/ijo.IJO_1439_21
   PubMed Web of Science ®Google Scholar
• Pagano L, Ricci P, Tonso A, et al. Mucormycosis in patients with haematological malignancies: a retrospective clinical study of 37 cases. GIMEMA Infection Program (Gruppo Italiano Malattie Ematologiche Maligne dell’Adulto). Br J Haematol. 1997;99(2):331–336. doi:10.1046/j.1365-2141.1997.3983214.x
   PubMed Web of Science ®Google Scholar
• Feng J, Sun X. Characteristics of pulmonary mucormycosis and predictive risk factors for the outcome. Infection. 2018;46(4):503–512.
   PubMed Web of Science ®Google Scholar
• Peng M, Meng H, Sun Y, et al. Clinical features of pulmonary mucormycosis in patients with different immune status. J Thorac Dis. 2019;11(12):5042–5052. doi:10.21037/jtd.2019.12.53
   PubMed Web of Science ®Google Scholar
• McAdams HP, Rosado de Christenson M, Strollo DC, et al. Pulmonary mucormycosis: radiologic findings in 32 cases. AJR Am J Roentgenol. 1997;168(6):1541–1548.
   PubMed Web of Science ®Google Scholar
• Lin CY, Liu WL, Chang CC, et al. Invasive fungal tracheobronchitis in mechanically ventilated critically ill patients: underlying conditions, diagnosis, and outcomes. Ann Intensive Care. 2017;7(1):9. doi:10.1186/s13613-016-0230-9
   PubMedGoogle Scholar
• Husari AW, Jensen WA, Kirsch CM, et al. Pulmonary mucormycosis presenting as an endobronchial lesion. Chest. 1994;106(6):1889–1891. doi:10.1378/chest.106.6.1889
   PubMed Web of Science ®Google Scholar
• Di Carlo P, Cabibi D, La Rocca AM, et al. Post-bronchoscopy fatal endobronchial hemorrhage in a woman with bronchopulmonary mucormycosis: a case report. J Med Case Rep. 2010;4(1):398. doi:10.1186/1752-1947-4-398
   PubMedGoogle Scholar
• Kim M, Lim JH, Park M, et al. A rare case of fatal endobronchial mucormycosis masquerading as endobronchial tuberculosis. Med (Kaunas). 2020;56(2):64. doi:10.3390/medicina56020064
   PubMed Web of Science ®Google Scholar
• Liu YN, She DY, Sun TY, et al. A multicentre retrospective study of pulmonary mycosis clinically proven from 1998 to 2007]. Zhonghua Jie He He Hu Xi Za Zhi. 2011;34:86–90.
   PubMedGoogle Scholar
• Pruthi H, Muthu V, Bhujade H, et al. Pulmonary artery pseudoaneurysm in COVID-19-associated pulmonary mucormycosis: case series and systematic review of the literature. Mycopathologia. 2022;187(1):31–37. doi:10.1007/s11046-021-00610-9
   PubMed Web of Science ®Google Scholar
• Jamadar DA, Kazerooni EA, Daly BD, et al. Pulmonary zygomycosis: cT appearance. J Comput Assist Tomogr. 1995;19:733–738.
   PubMed Web of Science ®Google Scholar
• Lin CY, Wang IT, Chang CC, et al. Comparison of clinical manifestation, diagnosis, and outcomes of invasive pulmonary aspergillosis and pulmonary mucormycosis. Microorganisms. 2019;7:531.
   PubMed Web of Science ®Google Scholar
• Hammer MM, Madan R, Hatabu H. Pulmonary mucormycosis: radiologic features at presentation and over time. AJR Am J Roentgenol. 2018;210(4):742–747.
   PubMed Web of Science ®Google Scholar
• Dykhuizen RS, Kerr KN, Soutar RL. Air crescent sign and fatal haemoptysis in pulmonary mucormycosis. Scand J Infect Dis. 1994;26(4):498–501.
   PubMed Web of Science ®Google Scholar
• Coffey MJ, Fantone J 3rd, Stirling MC, et al. Pseudoaneurysm of pulmonary artery in mucormycosis radiographic characteristics and management. Am Rev Respir Dis. 1992;145:1487–1490.
   PubMedGoogle Scholar
• Kitabayashi A, Hirokawa M, Yamaguchi A, et al. Invasive pulmonary mucormycosis with rupture of the thoracic aorta. Am J Hematol. 1998;58(4):326–329. doi:10.1002/(sici)1096-8652(199808)58:4<326:aid-ajh13>3.0.co;2-5
   PubMed Web of Science ®Google Scholar
• Grossi P, Farina C, Fiocchi R, et al. Prevalence and outcome of invasive fungal infections in 1,963 thoracic organ transplant recipients: a multicenter retrospective study. Italian study group of fungal infections in thoracic organ transplant recipients. Transplantation. 2000;70:112–116.
   PubMed Web of Science ®Google Scholar
• Bourcier J, Heudes PM, Morio F, et al. Prevalence of the reversed halo sign in neutropenic patients compared with non-neutropenic patients: data from a single-centre study involving 27 patients with pulmonary mucormycosis (2003-2016). Mycoses. 2017;60(8):526–533. doi:10.1111/myc.12624
   PubMed Web of Science ®Google Scholar
• Nam BD, Kim TJ, Lee KS, et al. Pulmonary mucormycosis: serial morphologic changes on computed tomography correlate with clinical and pathologic findings. Eur Radiol. 2018;28(2):788–795. doi:10.1007/s00330-017-5007-5
   PubMed Web of Science ®Google Scholar
• Skiada A, Drogari-Apiranthitou M, Pavleas I, et al. Global cutaneous mucormycosis: a systematic review. J Fungi (Basel). 2022;8:194.
   PubMedGoogle Scholar
• Zahoor B, Kent S, Wall D. Cutaneous mucormycosis secondary to penetrative trauma. Injury. 2016;47(7):1383–1387.
   PubMed Web of Science ®Google Scholar
• Zachary D, Chapin K, Binns L, et al. Cutaneous mucormycosis complicating a polymicrobial wound infection following a dog bite. Case Rep Infect Dis. 2011;2011:348046.
   PubMedGoogle Scholar
• Neblett Fanfair R, Benedict K, Bos J, et al. Necrotizing cutaneous mucormycosis after a tornado in Joplin, Missouri, in 2011. N Engl J Med. 2012;367(23):2214–2225. doi:10.1056/NEJMoa1204781
   PubMed Web of Science ®Google Scholar
• Planegger A, Uyulmaz S, Poskevicius A, et al. Cutaneous invasive fungal infections with Saksenaea species in immunocompetent patients in Europe: a systematic review and case report. Plast Reconstr Surg Glob Open. 2022;10(4):e4230. doi:10.1097/GOX.0000000000004230
   PubMedGoogle Scholar
• Wotiye AB, Ks P, Ayele BA. Invasive intestinal mucormycosis in a 40-year old immunocompetent patient - a rarely reported clinical phenomenon: a case report. BMC Gastroenterol. 2020;20:61.
   PubMed Web of Science ®Google Scholar
• Nandwani A, Jha PK, Duggal R, et al. Invasive gastric mucormycosis and cytomegalovirus infection in an ABO incompatible renal transplant recipient. Indian J Nephrol. 2015;25(6):373–376.
   PubMedGoogle Scholar
• Dioverti MV, Cawcutt KA, Abidi M, et al. Gastrointestinal mucormycosis in immunocompromised hosts. Mycoses. 2015;58(12):714–718. doi:10.1111/myc.12419
   PubMed Web of Science ®Google Scholar
• Kaur H, Ghosh A, Rudramurthy SM, et al. Gastrointestinal mucormycosis in apparently immunocompetent hosts-A review. Mycoses. 2018;61:898–908.
   PubMed Web of Science ®Google Scholar
• Chaudhary RJ, Choudhary NS, Saraf N, et al. Delayed graft dysfunction due to invasive hepatic mucormycosis after living donor liver transplantation. J Clin Exp Hepatol. 2020;10(6):629–632. doi:10.1016/j.jceh.2020.04.008
   PubMed Web of Science ®Google Scholar
• Elitzur S, Fischer S, Arad-Cohen N, et al. Disseminated mucormycosis in immunocompromised children: are new antifungal agents making a difference? A multicenter retrospective study. J Fungi (Basel). 2021;7(3).
   PubMedGoogle Scholar
• Mehta NN, Romanelli J, Sutton MG. Native aortic valve vegetative endocarditis with Cunninghamella. Eur J Echocardiogr. 2004;5:156–158.
   PubMedGoogle Scholar
• Sethia RK, Charag AH. A case of isolated unilateral renal mucormycosis post COVID-19 pneumonia with fatal outcome. Urol Case Rep. 2022;43:102061.
   PubMed Web of Science ®Google Scholar
• Frater JL, Hall GS, Procop GW. Histologic features of zygomycosis: emphasis on perineural invasion and fungal morphology. Arch Pathol Lab Med. 2001;125(3):375–378.
   PubMed Web of Science ®Google Scholar
• Skiada A, Lass-Floerl C, Klimko N, et al. Challenges in the diagnosis and treatment of mucormycosis. Med Mycol. 2018;56(suppl_1):93–101. doi:10.1093/mmy/myx101
   PubMed Web of Science ®Google Scholar
• Sharma S, Gupta P, Gupta N, et al. Pulmonary infections in immunocompromised patients: the role of image-guided fine needle aspiration cytology. Cytopathology. 2017;28(1):46–54. doi:10.1111/cyt.12359
   PubMed Web of Science ®Google Scholar
• Elgarten CW, Levy EM, Mattei P, et al. Successful treatment of pulmonary mucormycosis in two pediatric hematopoietic stem cell transplant patients. Pediatr Transplant. 2018;22(7):e13270. doi:10.1111/petr.13270
   PubMed Web of Science ®Google Scholar
• Pana ZD, Seidel D, Skiada A, et al. Invasive mucormycosis in children: an epidemiologic study in European and non-European countries based on two registries. BMC Infect Dis. 2016;16(1):667. doi:10.1186/s12879-016-2005-1
   PubMedGoogle Scholar
• Neofytos D, Fishman JA, Horn D, et al. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients. Transpl Infect Dis. 2010;12(3):220–229. doi:10.1111/j.1399-3062.2010.00492.x
   PubMed Web of Science ®Google Scholar
• Stern LE, Kagan RJ. Rhinocerebral mucormycosis in patients with burns: case report and review of the literature. J Burn Care Rehabil. 1999;20(4):303–306.
   PubMedGoogle Scholar
• Jestin M, Azoulay E, Pene F, et al. Poor outcome associated with mucormycosis in critically ill hematological patients: results of a multicenter study. Ann Intensive Care. 2021;11(1):31. doi:10.1186/s13613-021-00818-4
   PubMed Web of Science ®Google Scholar
• Garcia-Vidal C, Upton A, Kirby KA, et al. Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation. Clin Infect Dis. 2008;47(8):1041–1050. doi:10.1086/591969
   PubMed Web of Science ®Google Scholar
• Neofytos D, Treadway S, Ostrander D, et al. Epidemiology, outcomes, and mortality predictors of invasive mold infections among transplant recipients: a 10-year, single-center experience. Transpl Infect Dis. 2013;15(3):233–242. doi:10.1111/tid.12060
   PubMed Web of Science ®Google Scholar
• Pagano L, Caira M, Nosari A, et al. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study–sorveglianza epidemiologica infezioni fungine nelle emopatie maligne. Clin Infect Dis. 2007;45:1161–1170.
   PubMed Web of Science ®Google Scholar
• Roth RS, Masouridi-Levrat S, Chalandon Y, et al. Invasive mold infections in allogeneic hematopoietic cell transplant recipients in 2020: have we made enough progress? Open Forum Infect Dis. Open Forum Infect Dis. 2022;9(1):ofab596. doi:10.1093/ofid/ofab596.
   PubMed Web of Science ®Google Scholar
• Riches ML, Trifilio S, Chen M, et al. Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysis. Bone Marrow Transplant. 2016;51(2):277–282. doi:10.1038/bmt.2015.263
   PubMed Web of Science ®Google Scholar
• Husain S, Alexander BD, Munoz P, et al. Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi. Clin Infect Dis. 2003;37(2):221–229. doi:10.1086/375822
   PubMed Web of Science ®Google Scholar
• Hosseini-Moghaddam SM, Ouedraogo A, Naylor KL, et al. Incidence and outcomes of invasive fungal infection among solid organ transplant recipients: a population-based cohort study. Transpl Infect Dis. 2020;22(2):e13250. doi:10.1111/tid.13250
   PubMed Web of Science ®Google Scholar
• Guimaraes LF, Halpern M, de Lemos AS, et al. Invasive fungal disease in renal transplant recipients at a Brazilian center: local epidemiology matters. Transplant Proc. 2016;48(7):2306–2309. doi:10.1016/j.transproceed.2016.06.019
   PubMed Web of Science ®Google Scholar
• Song Y, Qiao J, Giovanni G, et al. Mucormycosis in renal transplant recipients: review of 174 reported cases. BMC Infect Dis. 2017;17:283. .
   PubMed Web of Science ®Google Scholar
• Garcia-Pajares F, Sanchez-Antolin G, Almohalla Alvarez C, et al. Cutaneous mucormycosis infection by Absidia in two consecutive liver transplant patients. Transplant Proc. 2012;44(6):1562–1564. doi:10.1016/j.transproceed.2012.05.022
   PubMed Web of Science ®Google Scholar
• Davari HR, Malekhossini SA, Salahi HA, et al. Outcome of mucormycosis in liver transplantation: four cases and a review of literature. Exp Clin Transplant. 2003;1:147–152.
   PubMedGoogle Scholar
• Do GW, Jung SW, Jun JB, et al. Colonic mucormycosis presented with ischemic colitis in a liver transplant recipient. World J Gastroenterol. 2013;19(22):3508–3511.
   PubMed Web of Science ®Google Scholar
• Ramos A, Cuervas-Mons V, Noblejas A, et al. Breakthrough rhinocerebral mucormycosis in a liver transplant patient receiving caspofungin. Transplant Proc. 2009;41(5):1972–1975. doi:10.1016/j.transproceed.2009.01.077
   PubMed Web of Science ®Google Scholar
• Rabin AS, Givertz MM, Couper GS, et al. Risk factors for invasive fungal disease in heart transplant recipients. J Heart Lung Transplant. 2015;34(2):227–232. doi:10.1016/j.healun.2014.09.036
   PubMed Web of Science ®Google Scholar
• Hill MC, Belkin MN, McMullen P 2nd, et al. Management of pulmonary mucormycosis after orthotopic heart transplant: a case series. Transplant Proc. 2021;53:3051–3055.
   PubMed Web of Science ®Google Scholar
• Chang A, Musk M, Lavender M, et al. Epidemiology of invasive fungal infections in lung transplant recipients in Western Australia. Transpl Infect Dis. 2019;21:e13085.
   PubMedGoogle Scholar
• Monforte A, Los-Arcos I, Martin-Gomez MT, et al. Safety and effectiveness of isavuconazole treatment for fungal infections in solid organ transplant recipients (ISASOT Study). Microbiol Spectr. 2022;10(1):e0178421. doi:10.1128/spectrum.01784-21
   PubMed Web of Science ®Google Scholar
• Zander DS, Cicale MJ, Mergo P. Durable cure of mucormycosis involving allograft and native lungs. J Heart Lung Transplant. 2000;19(6):615–618.
   PubMed Web of Science ®Google Scholar
• Silveira FP, Kwak EJ, Paterson DL, et al. Post-transplant colonization with non-Aspergillus molds and risk of development of invasive fungal disease in lung transplant recipients. J Heart Lung Transplant. 2008;27(8):850–855. doi:10.1016/j.healun.2008.05.021
   PubMed Web of Science ®Google Scholar
• Page AV, Evans AJ, Snell L, et al. Primary cutaneous mucormycosis in a lung transplant recipient: case report and concise review of the literature. Transpl Infect Dis. 2008;10(6):419–425.
   PubMed Web of Science ®Google Scholar
• Bhaskaran A, Hosseini-Moghaddam SM, Rotstein C, et al. Mold infections in lung transplant recipients. Semin Respir Crit Care Med. 2013;34(3):371–379.
   PubMed Web of Science ®Google Scholar
• Bardwell J, Youseffi B, Marquez J, et al. Pulmonary mucormycosis in a heart transplant patient. Am j med. 2020;133(9):e524–e5. doi:10.1016/j.amjmed.2020.02.020
   PubMed Web of Science ®Google Scholar
• Mills SEA, Yeldandi AV, Odell DD. Surgical treatment of multifocal pulmonary mucormycosis. Ann Thorac Surg. 2018;106:e93–e5.
   PubMed Web of Science ®Google Scholar
• Ghaderkhani S, Ahmadinejad Z, Dashti H, et al. Wound infection with an unusual pathogen after liver transplantation. Case Rep Transplant. 2020;2020:8396507.
   PubMedGoogle Scholar
• Mahalaxmi I, Jayaramayya K, Venkatesan D, et al. Mucormycosis: an opportunistic pathogen during COVID-19. Environ Res. 2021;201:111643.
   PubMed Web of Science ®Google Scholar
• Pushparaj K, Kuchi Bhotla H, Arumugam VA, et al. Mucormycosis (black fungus) ensuing COVID-19 and comorbidity meets - Magnifying global pandemic grieve and catastrophe begins. Sci Total Environ. 2022;805:150355.
   PubMed Web of Science ®Google Scholar
• Skiada A, Pavleas I, Drogari-Apiranthitou M. Epidemiology and diagnosis of mucormycosis: an Update. J Fungi (Basel). 2020;6(4):6.
   Google Scholar
• Scharmann U, Herbstreit F, Steckel NK, et al. Prevalence of COVID-19 associated mucormycosis in a German tertiary care hospital. J Fungi (Basel). 2022;8(3):307. doi:10.3390/jof8030307
   PubMedGoogle Scholar
• White PL. Diagnosis of invasive fungal disease in coronavirus disease 2019: approaches and pitfalls. Curr Opin Infect Dis. 2021;34(6):573–580.
   PubMed Web of Science ®Google Scholar
• Seidel D, Simon M, Sprute R, et al. Results from a national survey on COVID-19-associated mucormycosis in Germany: 13 patients from six tertiary hospitals. Mycoses. 2022;65(1):103–109. doi:10.1111/myc.13379
   PubMed Web of Science ®Google Scholar
• Guemas E, Cassaing S, Malavaud S, et al. A Clustered case series of mucorales detection in respiratory samples from COVID-19 patients in intensive care, France, August to September 2021. J Fungi (Basel). 2022;8(3):258. doi:10.3390/jof8030258
   PubMedGoogle Scholar
• Rabagliati R, Rodriguez N, Nunez C, et al. COVID-19-associated mold infection in critically ill patients, chile. Emerg Infect Dis. 2021;27:1454–1456.
   PubMed Web of Science ®Google Scholar
• SeyedAlinaghi S, Karimi A, Barzegary A, et al. Mucormycosis infection in patients with COVID-19: a systematic review. Health Sci Rep. 2022;5(2):e529. doi:10.1002/hsr2.529
   PubMedGoogle Scholar
• Bhattacharyya A, Sarma P, Kaur H, et al. COVID-19-associated rhino-orbital-cerebral mucormycosis: a systematic review, meta-analysis, and meta-regression analysis. Indian J Pharmacol. 2021;53:499–510.
   PubMed Web of Science ®Google Scholar
• Rudramurthy SM, Hoenigl M, Meis JF, et al. ECMM/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries. Mycoses. 2021;64(9):1028–1037. doi:10.1111/myc.13335
   PubMed Web of Science ®Google Scholar
• Moreira J, Ridolfi F, Almeida-Paes R, et al. Cutaneous mucormycosis in advanced HIV disease. Braz J Infect Dis. 2016;20:637–640.
   PubMed Web of Science ®Google Scholar
• Sanku K, Youssef D. Coexistence of mucormycosis and granulomatosis with polyangiitis: a diagnostic and therapeutic challenge. Cureus. 2022;14:e25124.
   PubMed Web of Science ®Google Scholar
• Shimoyama K, Niwa T, Furukawa S, et al. Behcet’s disease with bilateral renal infarction due to mucormycosis. Intern Med. 2022;61:1077–1083.
   PubMed Web of Science ®Google Scholar
• Nogueira EL, Ind PW, Friedland JS, et al. Mucormycosis may mimic disease relapse in wegener’s granulomatosis. J Rheumatol. 2010;37(6):1364–1365.
   PubMed Web of Science ®Google Scholar
• Bhatt H, Zilani G, Hayhurst C. Orbitocerebral mucormycosis and intracranial haemorrhage: a role for caution with steroids in suspected giant cell arteritis. BMJ Case Rep. 2018;2018:bcr-2017–224086.
   Google Scholar
• Muggeo P, Calore E, Decembrino N, et al. Invasive mucormycosis in children with cancer: a retrospective study from the infection working group of Italian pediatric hematology oncology association. Mycoses. 2019;62(2):165–170. doi:10.1111/myc.12862
   PubMed Web of Science ®Google Scholar
• Ruping MJ, Heinz WJ, Kindo AJ, et al. Forty-one recent cases of invasive zygomycosis from a global clinical registry. J Antimicrob Chemother. 2010;65:296–302.
   PubMed Web of Science ®Google Scholar
• Pagano L, Caira M, Candoni A, et al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica. 2006;91:1068–1075.
   PubMed Web of Science ®Google Scholar
• Zhanel G, Lynch JP, Fishbein M, et al. Part 2: mucormycosis: focus on therapy. Exp Rev Anti-Infective Therapy. 2023;21(7).
   Google Scholar